32 assets in T-Cell/Histiocyte Rich Large B Cell Lymphoma

Therapeutic assets addressing T-Cell/Histiocyte Rich Large B Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Vincristine Sulfate T-Cell/Histiocyte Rich Large B Cell Lymphoma	Northwestern University	P2/3	BB (67)
Adriamycin T-Cell/Histiocyte Rich Large B Cell Lymphoma	Ruijin Hospital	P2/3	BB (65)
Prednisone T-Cell/Histiocyte Rich Large B Cell Lymphoma	Ruijin Hospital	P2/3	BB (65)
Cyclophosphamide T-Cell/Histiocyte Rich Large B Cell Lymphoma	Ruijin Hospital	P2/3	BB (64)
Rituximab T-Cell/Histiocyte Rich Large B Cell Lymphoma	Ruijin Hospital	P2/3	BB (64)
Obinutuzumab T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	B (60)
Etoposide T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	B (58)
Nivolumab T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	B (58)
Polatuzumab Vedotin T-Cell/Histiocyte Rich Large B Cell Lymphoma	Ruijin Hospital	P2	B (58)
Azacitidine T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2/3	CCC (55)
Recombinant Human Hyaluronidase T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2/3	CCC (55)
Acalabrutinib T-Cell/Histiocyte Rich Large B Cell Lymphoma	Patrick C. Johnson, MD	P2	CCC (53)
Carboplatin T-Cell/Histiocyte Rich Large B Cell Lymphoma	David Bond, MD	P2	CCC (53)
Epcoritamab T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	CCC (53)
Fludeoxyglucose T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P2	CCC (53)
Golcadomide T-Cell/Histiocyte Rich Large B Cell Lymphoma	Mayo Clinic	P2	CCC (53)
Ibrutinib T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
Isocyclophosphamide T-Cell/Histiocyte Rich Large B Cell Lymphoma	David Bond, MD	P2	CCC (53)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor T-Cell/Histiocyte Rich Large B Cell Lymphoma	Patrick C. Johnson, MD	P2	CCC (53)
Lenalidomide T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
Ontorpacept T-Cell/Histiocyte Rich Large B Cell Lymphoma	Mayo Clinic	P2	CCC (53)
Pembrolizumab T-Cell/Histiocyte Rich Large B Cell Lymphoma	Jennifer Crombie, MD	P2	CCC (53)
Tafasitamab T-Cell/Histiocyte Rich Large B Cell Lymphoma	David Bond, MD	P2	CCC (53)
Venetoclax T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	CCC (53)
Zanubrutinib T-Cell/Histiocyte Rich Large B Cell Lymphoma	Northwestern University	P2	CCC (53)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer T-Cell/Histiocyte Rich Large B Cell Lymphoma	Mayo Clinic	P2	CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P2	CC (44)
Copanlisib T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Sgr-1505 T-Cell/Histiocyte Rich Large B Cell Lymphoma	Schrödinger, Inc.	P1	CC (43)
Synkir-310 T-Cell/Histiocyte Rich Large B Cell Lymphoma	Verismo Therapeutics	P1	CC (43)
(+)-Vincristine T-Cell/Histiocyte Rich Large B Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) T-Cell/Histiocyte Rich Large B Cell Lymphoma	University of Washington	P1	CC (41)